spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  vitiligo 

 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Oct 2022
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2021
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jan 2020
Bioniz Therapeutics enters into an option agreement for acquisition by Almirall of its lead clinical candidate BNZ-1 in development for immuno-dermatologic and onco-dermatologic diseases
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jul 2016
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 May 2016
Aclaris Therapeutics Announces $20.0 Million Private Placement
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Jun 2011
Avita Medical Reports Additional Market Acceptance of its ReCell(R) Spray-On-Skin(TM)
Devices Regenerative Medicine Dermatology
 HSMN NewsFeed - 5 Jan 2010
Levia(R) for Personal Targeted Phototherapy(TM) Treatment of Psoriasis Receives FDA 510(k) Clearance
Devices Dermatology FDA
 HSMN NewsFeed - 6 Jul 2009
PhotoMedex Appoints New CEO
Devices Dermatology Personnel
 HSMN NewsFeed - 1 Jun 2009
Introducing The Pioneering XTRAC Velocity Excimer Laser: Delivers Psoriasis And Vitiligo Treatments Three Times Faster
Devices Dermatology
 HSMN NewsFeed - 13 May 2008
PhotoMedex Receives FDA Clearance for the XTRAC(R) Velocity(TM) Laser
Devices Dermatology FDA
 HSMN NewsFeed - 13 May 2008
PhotoMedex Receives Positive Reimbursement Decision from BlueCross BlueShield of Massachusetts for XTRAC Laser System
Devices Dermatology Reimbursement
 HSMN NewsFeed - 18 Sep 2007
PhotoMedex Hires Paul TanPiengco as Director of Marketing
Devices Personnel
 HSMN NewsFeed - 7 Aug 2007
GammaCan Receives FDA Orphan Drug Designation for Lead Product VitiGam(TM) for Stage IIB to Stage IV Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jul 2007
Tru-Blu(TM) Light Treatment Approved for Acne
Devices Dermatology FDA
 HSMN NewsFeed - 31 Oct 2006
GammaCan International, Announces Appointment of Lynn Schuchter M.D. to its Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
vitiligo
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.